AD-specific cortical thinning is also shown to predict cognitive decline (Dickerson & Wolk, 2012;Sabuncu et al., 2011) and AD-related neuropathology (i.e., amyloid or tau positivity) (Pettigrew et al., 2023). Here, MAPT is linked to Alzheimer disease.